Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NeuroOne Medical Technologies Corporation (NMTC) had Return on Equity of -50.98% for the most recently reported fiscal year, ending 2025-09-30.
| Income Statement Financials | |
$12.10M |
|
$-3.61M |
|
$3.96M |
|
$8.14M |
|
$16.32M |
|
$-4.23M |
|
$0.62M |
|
$-3.61M |
|
$-3.61M |
|
$-3.61M |
|
$-3.61M |
|
$-3.61M |
|
$-3.61M |
|
$-4.23M |
|
$-3.77M |
|
40.15M |
|
40.15M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$10.23M |
|
$0.26M |
|
$0.56M |
|
$10.79M |
|
$2.30M |
|
-- |
|
$1.41M |
|
$3.71M |
|
$7.07M |
|
$7.03M |
|
$7.07M |
|
50.01M |
|
| Cash Flow Statement Financials | |
$-2.84M |
|
$-0.08M |
|
$8.03M |
|
$1.46M |
|
$6.57M |
|
$5.11M |
|
$1.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
67.30% |
|
-34.94% |
|
-34.94% |
|
-31.18% |
|
-29.80% |
|
-29.80% |
|
$-2.92M |
|
-- |
|
-- |
|
-- |
|
1.12 |
|
1.78 |
|
9.56 |
|
38.16 |
|
|
Return on Equity |
-50.98% |
-51.30% |
|
-33.43% |
|
-50.98% |
|
$0.14 |
|
$-0.07 |
|
$-0.07 |
|